213 related articles for article (PubMed ID: 12819009)
21. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation profile of kidney cancer.
Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
[TBL] [Abstract][Full Text] [Related]
23. Oligonucleotide-based microarray for DNA methylation analysis: principles and applications.
Shi H; Maier S; Nimmrich I; Yan PS; Caldwell CW; Olek A; Huang TH
J Cell Biochem; 2003 Jan; 88(1):138-43. PubMed ID: 12461783
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation in histologically distinct classes of breast cancer.
Bae YK; Brown A; Garrett E; Bornman D; Fackler MJ; Sukumar S; Herman JG; Gabrielson E
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5998-6005. PubMed ID: 15447983
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
27. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
29. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas.
Laux DE; Curran EM; Welshons WV; Lubahn DB; Huang TH
Breast Cancer Res Treat; 1999 Jul; 56(1):35-43. PubMed ID: 10517341
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
[TBL] [Abstract][Full Text] [Related]
32. Aberrant methylation of the THRB gene in tissue and plasma of breast cancer patients.
Ling Y; Xu X; Hao J; Ling X; Du X; Liu X; Zhao X
Cancer Genet Cytogenet; 2010 Jan; 196(2):140-5. PubMed ID: 20082849
[TBL] [Abstract][Full Text] [Related]
33. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
34. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
[TBL] [Abstract][Full Text] [Related]
35. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique.
Huang TH; Laux DE; Hamlin BC; Tran P; Tran H; Lubahn DB
Cancer Res; 1997 Mar; 57(6):1030-4. PubMed ID: 9067264
[TBL] [Abstract][Full Text] [Related]
36. Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.
Tommasi S; Karm DL; Wu X; Yen Y; Pfeifer GP
Breast Cancer Res; 2009; 11(1):R14. PubMed ID: 19250546
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
Rice JC; Massey-Brown KS; Futscher BW
Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis.
Tan J; Gu Y; Zhang X; You S; Lu X; Chen S; Han X; Sun Y
Clin Exp Med; 2013 Feb; 13(1):1-9. PubMed ID: 22212995
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.
Kim MS; Lee J; Oh T; Moon Y; Chang E; Seo KS; Hoehn BD; An S; Lee JH
Oncol Rep; 2012 May; 27(5):1681-8. PubMed ID: 22366991
[TBL] [Abstract][Full Text] [Related]
40. Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation.
Yan PS; Efferth T; Chen HL; Lin J; Rödel F; Fuzesi L; Huang TH
Methods; 2002 Jun; 27(2):162-9. PubMed ID: 12095276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
